New “Buy” Rating Was Given to Chimerix (NASDAQ:CMRX)
Why Has UBS Given Chimerix (NASDAQ:CMRX) a $55.0 Price Target In an analyst note revealed to clients and investors today, UBS analysts have begun Chimerix…
Chimerix – (NASDAQ:CMRX)
Chimerix (NASDAQ:CMRX) Is Now Covered By UBS. What can We Expect?
Why Has UBS Given Chimerix (NASDAQ:CMRX) a $55 Price Target UBS initiated its coverage for Chimerix (NASDAQ:CMRX), this morning 17 December. The firm found the…
